AI Article Synopsis
- Yamaguchi syndrome, also known as apical hypertrophic cardiomyopathy, is a rare type of non-obstructive hypertrophic cardiomyopathy characterized by thickening of the left ventricular apex.
- This condition is most commonly observed in Asian populations but can occur in other ethnic groups as well.
- The text discusses an unusual case of Yamaguchi syndrome in a Hispanic female, highlighting the rarity of the condition outside typical demographic groups.
Article Abstract
Yamaguchi syndrome or apical hypertrophic cardiomyopathy is a rare subtype of non-obstructive hypertrophic cardiomyopathy that is defined as the focused hypertrophy of the left ventricular apex. It is typically seen in Asian populations. Herein, we present a rare case of Yamaguchi syndrome seen in a Hispanic female.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10972733 | PMC |
| http://dx.doi.org/10.7759/cureus.54985 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Effect of Coronary Artery Disease on the Prognosis of Hypertrophic Cardiomyopathy: A Multi-Center Cohort Study.
Rev Cardiovasc Med
January 2025
Department of Cardiology, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, 610072 Chengdu, Sichuan, China.
Background: There is a shortage of patients with hypertrophic cardiomyopathy (HCM) with concurrent coronary artery disease (CAD), and the influence of CAD on the prognosis of patients with HCM is uncertain. This real-world cohort study was conducted to evaluate the prognosis of patients with patients with CAD.
Methods: This cohort study of patients with HCM was conducted from May 2003 to September 2021.
Pathogenic genes and clinical prognosis in hypertrophic cardiomyopathy.
World J Cardiol
January 2025
Institute of Cardiovascular Diseases & Department of Cardiology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, Sichuan Province, China.
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited cardiomyopathy characterized by left ventricular hypertrophy. It is one of the chief causes of sudden cardiac death in younger people and athletes. Molecular-genetic studies have confirmed that the vast majority of HCM is caused by mutations in genes encoding sarcomere proteins.
View Article and Find Full Text PDFMono and Biallelic Variants in Are Frequently Associated With a Unique Form of Hypertrophic Cardiomyopathy.
Circ Genom Precis Med
January 2025
Clalit Research Institute, Clalit Health Services, Ramat Gan, Israel (R.G., O.I., S.B.-S.).
Author's Reply to Impact of Mavacamten on Atrial Fibrillation in Patients with Obstructive Hypertrophic Cardiomyopathy.
Heart Rhythm
January 2025
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA; Department of Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory). Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!